Merit Medical Systems MMSI Research and development expense
Research and development expense at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Merit Medical Systems's research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Merit Medical Systems's research and development expense?
- Merit Medical Systems (MMSI) reported research and development expense of $22.61M in Q1 2026.
- How has Merit Medical Systems's research and development expense changed year-over-year?
- Merit Medical Systems's research and development expense increased by 0.6% year-over-year, from $22.48M to $22.61M.
- What is the long-term trend for Merit Medical Systems's research and development expense?
- Over 4 years (2021 to 2025), Merit Medical Systems's research and development expense has grown at a 8.1% compound annual growth rate (CAGR), from $71.25M to $97.35M.